Translation of Reporting Entity’s Statements of Net Assets. A reporting entity reports in local currency. All reports are translated into US Dollars by the Seller for reporting purposes. The Novartis Statement of Net Assets is translated with the period-end exchange rates which are the rates provided by Novartis Group Treasury and are based on Bloomberg’s mid-morning CET exchange rates and are published in the Group Treasury section of the Novartis intranet.
Appears in 4 contracts
Samples: Contribution Agreement (Glaxosmithkline PLC), Contribution Agreement (Glaxosmithkline PLC), Contribution Agreement (Novartis Ag)
Translation of Reporting Entity’s Statements of Net Assets. A reporting entity reports in local currency. All reports are translated into US Dollars dollars by the Seller for reporting purposes. The Novartis Statement of Net Assets is translated with the period-end exchange rates which are the rates provided by Novartis Group Treasury and are based on Bloomberg’s mid-morning CET exchange rates and are published in the Group Treasury section of the Novartis intranet.
Appears in 3 contracts
Samples: Share and Business Sale Agreement (Glaxosmithkline PLC), Share and Business Sale Agreement (Novartis Ag), Share and Business Sale Agreement (Glaxosmithkline PLC)
Translation of Reporting Entity’s Statements of Net Assets. A reporting entity reports in local currency. All reports are translated into US Dollars by the Seller for reporting purposes. The Novartis Statement of Net Assets is translated with the period-end exchange rates which are the rates provided by Novartis Group Treasury and are based on Bloomberg’s mid-morning CET exchange rates and are published in the Group Treasury section of the Novartis intranet.
Appears in 1 contract
